4.7 Article

Risk factors for hepatic encephalopathy in patients with cirrhosis and refractory ascites: relevance of serum sodium concentration

Journal

LIVER INTERNATIONAL
Volume 30, Issue 8, Pages 1137-1142

Publisher

WILEY
DOI: 10.1111/j.1478-3231.2010.02293.x

Keywords

cirrhosis; hepatic encephalopathy; hyponatraemia; TIPS

Funding

  1. Fondo de Investigacion Sanitaria [FIS 080108]
  2. Instituto de Investigacion Nefrologica Reina Sofia
  3. Fundacion Banco Bilbao-Viscaya-Argentaria (FBBVA)

Ask authors/readers for more resources

Hyponatraemia is common in patients with advanced cirrhosis and is associated with remarkable changes in brain cells, particularly a reduction in myoinositol and other intracellular organic osmolytes related to the hypo-osmolality of the extracellular fluid. It has been recently suggested that hyponatraemia may be an important factor associated with the development of overt hepatic encephalopathy (HE). To test this hypothesis, we retrospectively analysed the incidence and predictive factors of overt HE using a database of 70 patients with cirrhosis included in a prospective study comparing transjugular intrahepatic portosystemic shunts (TIPS) vs large-volume paracentesis in the management of refractory of ascites. Variables used in the analysis included age, sex, previous history of HE, treatment assignment (TIPS vs large volume paracentesis plus albumin), treatment with diuretics, serum bilirubin, serum creatinine and serum sodium concentration. Laboratory parameters were measured at entry, at 1 month and every 3 months during follow-up and at the time of development of HE in patients who developed this complication. During a mean follow-up of 10 months, 50 patients (71%) developed 117 episodes of HE. In the whole population of patients, the occurrence of HE was independently associated with serum hyponatraemia, serum bilirubin and serum creatinine. In conclusion, in patients with refractory ascites, the occurrence of HE is related to the impairment of liver and renal function and presence of hyponatraemia.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Immunology

Liver Transplantation for Porto-sinusoidal Vascular Liver Disorder: Long-term Outcome

Marta Magaz, Heloise Giudicelli-Lett, Oana Nicoara-Farcau, Neil Rajoriya, Ashish Goel, Karlien Raymenants, Sophie Hillaire, Gonzalo Crespo, Luis Tellez, Laure Elkrief, Constantino Fondevila, Lara Orts, Filipe Nery, Akash Shukla, Helene Larrue, Yiliam Fundora, Helena Degroote, Victoria Aguilera, Elba LLop, Laura Turco, Federica Indulti, Stefania Gioia, Giulia Tosetti, Niccolo Bitto, Chiara Becchetti, Edilmar Alvarado, Cristina Roig, Raquel Diaz, Michael Praktiknjo, Anna-Lena Konicek, Guillem Soy, Pol Olivas, Jose Ignacio Fortea, Helena Masnou, Angela Puente, Alba Ardevol, Carmen Alvarez-Navascues, Marta Romero, Bernhard Scheiner, Georg Semmler, Mattias Mandorfer, Filipe Damiao, Anna Baiges, Fanny Turon, Macarena Simon-Talero, Carlos Gonzalez-Alayon, Alba Diaz, Angeles Garcia-Criado, Andrea de Gottardi, Enric Reverter, Annabel Blasi, Joan Genesca, Olivier Roux, Claire Francoz, Carlos Noronha Ferreira, Thomas Reiberger, Manuel Rodriguez, Rosa Maria Morillas, Javier Crespo, Jonel Trebicka, Rafael Banares, Candid Villanueva, Annalisa Berzigotti, Massimo Primignani, Vincenzo La Mura, Oliviero Riggio, Filippo Schepis, Bogdan Procopet, Xavier Verhelst, Jose Luis Calleja, Christophe Bureau, Agustin Albillos, Frederik Nevens, Virginia Hernandez-Gea, Dhiraj Tripathi, Pierre-Emmanuel Rautou, Francois Durand, Juan Carlos Garcia-Pagan

Summary: This study aimed to identify features associated with post-LT outcomes in PSVD. The results showed that patients without associated severe conditions had better survival rates after LT, while pre-LT high bilirubin levels and creatinine >100 μmol/L were associated with poor survival.

TRANSPLANTATION (2023)

Article Microbiology

Akkermansia deficiency and mucin depletion are implicated in intestinal barrier dysfunction as earlier event in the development of inflammation in interleukin-10-deficient mice

Beatriz Lopez-Cauce, Marta Puerto, Juan Jose Garcia, Manuel Ponce-Alonso, Federico Becerra-Aparicio, Rosa del Campo, Isabel Peligros, Maria J. Fernandez-Acenero, Yesica Gomez-Navarro, Jose M. Lara, Jose Miranda-Bautista, Ignacio Marin-Jimenez, Rafael Banares, Luis Menchen

Summary: Inflammatory bowel disease (IBD) is associated with dysbiosis and mucin depletion, which lead to intestinal barrier dysfunction. This study examines these parameters in IL-10 deficient mice and finds that gut microbiota alterations and mucin depletion precede overt gut inflammation in this animal model of IBD.

FRONTIERS IN MICROBIOLOGY (2023)

Article Gastroenterology & Hepatology

Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries

Homie A. Razavi, Maria Buti, Norah A. Terrault, Stefan Zeuzem, Cihan Yurdaydin, Junko Tanaka, Alessio Aghemo, Ulus S. Akarca, Nasser M. Al Masri, Abduljaleel M. Alalwan, Soo Aleman, Abdullah S. Alghamdi, Saad Alghamdi, Waleed K. Al-Hamoudi, Abdulrahman A. Aljumah, Ibrahim H. Altraif, Tarik Asselah, Ziv Ben-Ari, Thomas Berg, Mia J. Biondi, Sarah Blach, Wornei S. M. Braga, Carlos E. Brandao-Mello, Maurizia R. Brunetto, Joaquin Cabezas, Hugo Cheinquer, Pei-Jer Chen, Myeong-Eun Cheon, Wan-Long Chuang, Carla S. Coffin, Nicola Coppola, Antonio Craxi, Javier Crespo, Victor De Ledinghen, Ann-Sofi Duberg, Ohad Etzion, Maria Lucia G. Ferraz, Paulo R. A. Ferreira, Xavier Forns, Graham R. Foster, Giovanni B. Gaeta, Ivane Gamkrelidze, Javier Garcia-Samaniego, Liliana S. Gheorghe, Pierre M. Gholam, Robert G. Gish, Jeffrey Glenn, Julian Hercun, Yao-Chun Hsu, Ching-Chih Hu, Jee-Fu Huang, Naveed Janjua, Jidong Jia, Martin Kaberg, Kelly D. E. Kaita, Habiba Kamal, Jia-Horng Kao, Loreta A. Kondili, Martin Lagging, Pablo Lazaro, Jeffrey V. Lazarus, Mei-Hsuan Lee, Young-Suk Lim, Paul J. Marotta, Maria-Cristina Navas, Marcelo C. M. Naveira, Mauricio Orrego, Carla Osiowy, Calvin Q. Pan, Mario G. Pessoa, Giovanni Raimondo, Alnoor Ramji, Devin M. Razavi-Shearer, Kathryn Razavi-Shearer, Cielo Y. Rios-Hincapie, Manuel Rodriguez, William M. C. Rosenberg, Dominique M. Roulot, Stephen D. Ryder, Rifaat Safadi, Faisal M. Sanai, Teresa A. Santantonio, Christoph Sarrazin, Daniel Shouval, Frank Tacke, Tammo L. Tergast, Juan Miguel Villalobos-Salcedo, Alexis S. Voeller, Hwai-I Yang, Ming-Lung Yu, Eli Zuckerman

Summary: Hepatitis D virus (HDV) coinfection with hepatitis B increases the risk of liver cancer, cirrhosis, and death compared to hepatitis B monoinfection. Accurate estimates of HDV prevalence are needed to effectively identify coinfected individuals. Implementing double reflex testing, including anti-HDV testing and HDV RNA testing, is the most effective method to generate estimates and identify undiagnosed individuals. This strategy is feasible and requires a relatively low number of tests.

JOURNAL OF HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

A global research priority agenda to advance public health responses to fatty liver disease

Jeffrey V. Lazarus, Henry E. Mark, Alina M. Allen, Juan Pablo Arab, Patrizia Carrieri, Mazen Noureddin, William Alazawi, Naim Alkhouri, Saleh A. Alqahtani, Marco Arrese, Ramon Bataller, Thomas Berg, Paul N. Brennan, Patrizia Burra, Graciela E. Castro-Narro, Helena Cortez-Pinto, Kenneth Cusi, Nikos Dedes, Ajay Duseja, Sven M. Francque, Hannes Hagstrom, Terry T. -K. Huang, Dana Ivancovsky Wajcman, Achim Kautz, Christopher J. Kopka, Aleksander Krag, Veronica Miller, Philip N. Newsome, Mary E. Rinella, Diana Romero, Shiv Kumar Sarin, Marcelo Silva, C. Wendy Spearman, Emmanuel A. Tsochatzis, Luca Valenti, Marcela Villota-Rivas, Shira Zelber-Sagi, Jorn M. Schattenberg, Vincent Wai-Sun Wong, Zobair M. Younossi

Summary: This study aimed to develop a research agenda for fatty liver disease, and 28 priorities were identified to address the individual and societal harms caused by this disease. Adopting this agenda can accelerate global efforts to respond to this public health threat.

JOURNAL OF HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma

Mario Romero-Cristobal, Ana Clemente-Sanchez, Enrique Ramon, Luis Tellez, Elena Canales, Olga Ortega-Lobete, Elena Velilla-Aparicio, Maria -Vega Catalina, Luis Ibanez-Samaniego, Sonia Alonso, Arturo Colon, Ana-Maria Matilla, Magdalena Salcedo, Agustin Albillos, Rafael Banares, Diego Rincon

Summary: Liver and spleen volume measurements obtained through MDCT can accurately predict portal hypertension in patients with HCC. This simple and reliable measurement method can assist in assessing surgical risks.

JHEP REPORTS (2023)

Editorial Material Gastroenterology & Hepatology

The path to successful hepatitis C elimination in Spain

Javier Crespo, Joaquin Cabezas, Jose Luis Calleja, Maria Buti, Jeffrey V. Lazarus

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Article Medicine, General & Internal

Mirikizumab as Induction and Maintenance Therapy for Ulcerative Colitis

Geert D'Haens, Marla Dubinsky, Taku Kobayashi, Peter M. Irving, Stefanie Howaldt, Juris Pokrotnieks, Kathryn Krueger, Janelle Laskowski, Xingyuan Li, Trevor Lissoos, Joe Milata, Nathan Morris, Vipin Arora, Catherine Milch, William Sandborn, Bruce E. Sands

Summary: Mirikizumab was superior to placebo in inducing and maintaining clinical remission in patients with moderately to severely active ulcerative colitis. Adverse events such as nasopharyngitis and arthralgia were reported more frequently in the Mirikizumab group. Only a small number of patients treated with Mirikizumab had opportunistic infections or cancer.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Article Cell Biology

Neuroblastoma RAS viral oncogene homolog (N-RAS) deficiency aggravates liver injury and fibrosis

Kang Zheng, Fengjie Hao, Sandra Medrano-Garcia, Chaobo Chen, Feifei Guo, Laura Moran-Blanco, Sandra Rodriguez-Perales, Raul Torres-Ruiz, Maria Isabel Peligros, Javier Vaquero, Rafael Banares, Manuel Gomez del Moral, Jose R. Regueiro, Eduardo Martinez-Naves, Mohamed Ramadan Mohamed, Rocio Gallego-Duran, Douglas Maya, Javier Ampuero, Manuel Romero-Gomez, Albert Gilbert-Ramos, Sergi Guixe-Muntet, Anabel Fernandez-Iglesias, Jordi Gracia-Sancho, Mar Coll, Isabel Graupera, Pere Gines, Andreea Ciudin, Jesus Rivera-Esteban, Juan M. Pericas, Maria Dolores Frutos, Bruno Ramos Molina, Jose Maria Herranz, Matias A. Avila, Yulia A. Nevzorova, Edgar Fernandez-Malave, Francisco Javier Cubero

Summary: Progressive hepatic damage and fibrosis in chronic liver diseases can be controlled by N-RAS through downregulation of signaling pathways leading to hepatocyte necroptosis. This study suggests that N-RAS may have potential as a prognostic biomarker and therapeutic target for chronic liver diseases.

CELL DEATH & DISEASE (2023)

Article Emergency Medicine

Sex-related differences in benefits of anticoagulation therapy in elderly patients with atrial fibrillation: a subanalysis of the EMERG-AF study

Mercedes Varona, Alfonso Martin, Juan Sanchez, Juan Tamargo, Manuel Cancio, Susana Sanchez, Jose Carbajosa, Amparo Fernandez de Simon, Jose Rios, Carmen del Arco, Jose Ormaetxe, Coral Suero, Blanca Coll-Vinent

Summary: This study analyzed the long-term benefits and safety of oral anticoagulation therapy prescribed in emergency departments for elderly patients with atrial fibrillation, and detected sex-related differences. The results showed that ED anticoagulant prescription is safe and contributes to a reduction in mortality for elderly patients with atrial fibrillation. Specifically, women in this age group benefited more from starting anticoagulation during the acute phase in the ED.

EMERGENCIAS (2023)

Article Gastroenterology & Hepatology

Implementation and impact of an antibiotic control program and multidrug-resistant bacterial colonization in a liver transplant unit

Ainhoa Fernandez, Clara Diez-Picazo, Carmen Iglesias, Celia Trueba, Mario Romero, Fernando Diaz, Aranzazu Caballero, Maricela Valerio, Maria Olmedo, Teresa Vicente, Belen Padilla, Rafael Ramos, Jose Angel Lopez, Patricia Munoz, Rafael Banares, Magdalena Salcedo

Summary: Infections caused by multidrug-resistant bacteria are a significant problem for transplant patients. This retrospective study evaluated the impact of an Antimicrobial Treatment Optimization Program (PROA) on multidrug-resistant bacterial colonization and infection after liver transplantation. The results showed that there was good adherence to the PROA, and infection was the most common cause of readmission in the first year after transplantation. The incidence of infections was similar before and after PROA implementation, but there was a decrease in the number of multidrug-resistant bacterial infections.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2023)

Review Biochemistry & Molecular Biology

Innovative Therapeutic Approaches in Non-Alcoholic Fatty Liver Disease: When Knowing Your Patient Is Key

Marta Alonso-Pena, Maria Del Barrio, Ana Peleteiro-Vigil, Carolina Jimenez-Gonzalez, Alvaro Santos-Laso, Maria Teresa Arias-Loste, Paula Iruzubieta, Javier Crespo

Summary: Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disorders ranging from simple steatosis to non-alcoholic steatohepatitis (NASH). NAFLD could result from dysfunction in multiple pathways and various molecular triggers. NASH involves inflammatory and fibrotic processes. Additionally, NAFLD is closely associated with several extra-hepatic comorbidities. Due to the heterogeneity and multifactorial etiology of NAFLD, clinical trials for treatment have had limited success. A narrative review of the phenotypic characteristics of NAFLD patients and personalized treatment could lead to better outcomes.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Gastroenterology & Hepatology

Current state of telemedicine in the field of Hepatology in Spain: challenges, threats and next steps to follow for an intelligent digital transformation

Javier Crespo, Joaquin Cabezas, Miguel Mateo, Alberto de la Cuadra-Grande, Miguel Angel Casado, Jeffrey V. Lazarus, Jose Luis Calleja

Summary: This study conducts a systematic review and meta-analysis to define the concepts of telemedicine, its application, and the legal regulatory context. It also proposes recommendations and codes of good practice for the effective implementation of telemedicine in Hepatology.

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2023)

Article Gastroenterology & Hepatology

Oportunistic diagnosis based on age and hepatitis C virus clearance: an essential step to improve the overall health of the liver

Javier Crespo, Joaquin Cabezas, Antonio Aguilera, Agustin Albillos, Maria Buti, Jose Luis Calleja, Jorge Calvo Montes, Marta Casado Martin, Moises Diago, Conrado M. Fernandez Rodriguez, Inmaculada Fernandez Vazquez, Xavier Forns, Federico Garcia, Javier Garcia-Samaniego, Manuel Hernandez-Guerra de Aguilar, Francisco Jorquera, Jeffrey Lazarus, Sabela Lens, Elisa Martro, Jose Maria Molero Garcia, Maria Jose Pena Lopez, Juan Antonio Pineda, Manuel Rodriguez, Manuel Romero-Gomez, Gloria Sanchez Antolin, Miguel A. Serra Desfilis, Juan Turnes

REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS (2023)

Article Clinical Neurology

Periaqueductal gray matter echogenicity as a marker of migraine chronification: a case control study

Dolores Vilas, Sara Rubio, Mireia Gea, Jose Rios, Lourdes Ispierto, Maria Hernandez-Perez, Marti Pare, Monica Millan, Laura Dorado

Summary: Through transcranial ultrasound, it was found that patients with chronic migraines had a larger echogenicity area of the periaqueductal gray matter, lower intensity of echogenicity, and higher heterogeneity within this brainstem structure compared to patients with episodic migraines and controls. The echogenicity of the periaqueductal gray matter should be further investigated as a biomarker of migraine chronification.

JOURNAL OF HEADACHE AND PAIN (2023)

Article Gastroenterology & Hepatology

No evidence of association between inherited thrombophilia and increased risk of liver fibrosis

Iranzu Ezcurra, Angela Puente, Antonio Cuadrado, Ibai Tamayo, Paula Iruzubieta, Maria Teresa Arias-Loste, Francisco Jose Gonzalez, Raul Pellon, Sara Sanchez, Juan Crespo, Mercedes Acebo, Marcos Lopez-Hoyos, Rocio Perez, Amalia Cuesta, Angela Anton, Victor Echavarria, Emilio Fabrega, Javier Crespo, Jose Ignacio Fortea

Summary: This study aimed to investigate the prevalence of significant fibrosis in patients with inherited thrombophilia and compare it with a large population-based cohort. The results showed no evidence of an association between inherited thrombophilia and an increased risk of significant liver fibrosis.

UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2023)

No Data Available